Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
出版年份 2019 全文链接
标题
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-04-03
DOI
10.1038/s41598-019-42069-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement
- (2017) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Quality of life, long-term survivors and long-term outcome from the ABC-02 study
- (2016) John Bridgewater et al. BRITISH JOURNAL OF CANCER
- Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance
- (2016) Daniel H. Ahn et al. CANCER
- Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection
- (2016) Michael Stotz et al. PLoS One
- Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers
- (2016) Christian Mayr et al. Biomed Research International
- Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues
- (2015) Bertrand Brieau et al. CANCER
- Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease
- (2015) Angela Lamarca et al. EUROPEAN JOURNAL OF CANCER
- FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients
- (2015) Chandragouda Dodagoudar et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data
- (2015) Lorenzo Fornaro et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma
- (2015) Joannis Panotopoulos et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
- (2015) Jean-Florian Guion-Dusserre et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
- (2015) Christian Mayr et al. Oncotarget
- Second-line chemotherapy in advanced biliary cancer: a systematic review
- (2014) A. Lamarca et al. ANNALS OF ONCOLOGY
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials
- (2013) J. W. Valle et al. ANNALS OF ONCOLOGY
- Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
- (2013) J Szkandera et al. BRITISH JOURNAL OF CANCER
- The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments
- (2013) Peter C. Austin STATISTICS IN MEDICINE
- Classification, Diagnosis, and Management of Cholangiocarcinoma
- (2012) Nataliya Razumilava et al. Clinical Gastroenterology and Hepatology
- Outcome of second-line chemotherapy for biliary tract cancer
- (2012) John Bridgewater et al. EUROPEAN JOURNAL OF CANCER
- Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
- (2012) Thomas Walter et al. EUROPEAN JOURNAL OF CANCER
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple imputation using chained equations: Issues and guidance for practice
- (2010) Ian R. White et al. STATISTICS IN MEDICINE
- Predictive and prognostic molecular markers for cancer medicine
- (2010) Sunali Mehta et al. Therapeutic Advances in Medical Oncology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started